Live
10x Genomics Blog10x Genomics (NASDAQ: TXG) grants 8,829 RSUs to director Suliman - Stock Titan10x Genomics Blog10x Genomics (TXG) awards 8,829 RSUs to board director - Stock Titan10x Genomics News10x Genomics (TXG) awards director Kimberly Popovits 8,829 RSUs - Stock Titan10x Genomics News10x Genomics (TXG) director receives 8,829 RSU grant, lifts holdings - Stock Titan10x Genomics News10x Genomics shareholders elect directors and approve proposals at annual meeting - Investing.com10x Genomics Blog10x Genomics shareholders elect directors and approve proposals at annual meeting - Investing.com10x Genomics Blog10x Genomics (NASDAQ: TXG) investors approve full 2026 meeting agenda - Stock TitanFierceBiotechCity aims to lay foundation for RNAi renaissance with nearly $100M series BEli LillyBig Pharma Stock Eli Lilly Concocts New Buy Zone - Investor's Business DailyEndpoints News#ADA26: AstraZeneca GLP-1 pill cuts weight 10.5% after six monthsVertexKyverna vs. Vertex: Clinical-Stage Risk vs. Cash-Flow Stability in Biotech Investing - News and Statistics - IndexBoxRoche MediaRoche and Nurix Therapeutics Announce Global Collaboration | PharmExec - Pharmaceutical Executive
Endpoints News 22. Dez. 2025

Ipsen gains access to ADC from Shanghai biotech Simcere Zaiming

Ipsen gains access to ADC from Shanghai biotech Simcere Zaiming

Original
Inhalt nicht verfügbar. Bitte die Originalquelle aufrufen.